Pay in 4 interest-free payments of $5.90 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
By reinforcing the concept of a durable, possibly neuroprotective effect, this study strengthened the rationale for GLP-1 RAs as disease-modifying candidates in Parkinsons disease and supported the design of larger randomized trials
The Medicare GLP-1 Bridge program offers a new, affordable path to an FDA-approved treatment that was previously not covered," said Jamey Millar, Executive Vice President, US Operations of Novo Nordisk
[PMID: 10707891] PubMed record related to this compound for laboratory literature review
!
US$ 22.35
US$ 26.46
US$ 20.76
US$ 26.78
US$ 24.98
US$ 25.18
US$ 28.15
US$ 29.51
